Latest filing published 21 Oct 2026 for Disc Medicine, Inc., €2.4M.
Filings by Atlas Venture Fund X, LP span 2 companies, the busiest being Kymera Therapeutics, Inc. and Disc Medicine, Inc. Over a trading history stretching from 17 June 2026 to 21 October 2026, the count stands at 13 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 21 October 2026 came the latest disclosure, a transaction for €2.4M in Disc Medicine, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations